Editorial: Artificial intelligence advancing lung cancer screening and treatment
By
Sunyi Zheng
Nanna Maria Sijtsema
Chunliang Wang
Marly Van Assen
Xiaonan Cui
June 9, 2026
Clinical Report: The Role of Artificial Intelligence in Enhancing Lung Cancer Detection and Management
Overview Revise to focus solely on the transition from traditional imaging methods to AI-driven approaches without implying potential.
Background Remove generalizations about AI's promise; stick to facts about lung cancer and current challenges.
Data Highlights No specific numerical data provided in the source material.
Key Findings AI can enhance lung cancer screening by integrating multimodal approaches, including serum biomarkers and alternative imaging modalities. Quantitative imaging analysis through radiomics improves diagnostic accuracy beyond visual interpretation. AI models can predict molecular characteristics and treatment responses, linking imaging findings with tumor biology. Machine learning can approximate complex clinical decision-making processes, supporting treatment planning. AI applications extend across the patient trajectory, from diagnosis to treatment selection and prognostic modeling. Clinical Implications The integration of AI in lung cancer care may facilitate earlier detection and more personalized treatment strategies. Clinicians should consider the evolving role of AI in enhancing diagnostic accuracy and supporting decision-making processes.
Conclusion Revise to avoid unsupported claims about opportunities and focus on the need for further validation.
Related Resources & Content
ASCO AI in Oncology, ASCO, 2026 -- AI-Assisted Multistep Lung Cancer Screening Program Boosts Uptake Beyond National Averages European Radiology, 2026 -- Commercial AI for CT lung cancer screening: product capabilities, coverage of nodule management tasks and supporting evidence The ASCO Post, 2026 -- AI Use in Cancer Diagnosis, Prognosis, and Treatment: Are We There Yet? European Radiology, 2023 -- A Comprehensive Guide to the Role of Artificial Intelligence in Thoracic Imaging: Insights from the European Society of Thoracic Imaging (ESTI) WHO, 2022 -- Lung cancer PubMed, 2025 -- Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Lung cancer Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up - PubMed
